Doctors Aim to Loosen Anemia Drug Limits
September 1st, 2007 By MATTHEW PERRONE, AP Business Writer(AP) -- Cancer doctors seek to loosen federal restrictions on anemia drugs that carry potentially deadly side effects, saying the tight payment guidelines for treatments made by Amgen and Johnson and Johnson are ultimately bad for patients.
Content from The Associated Press expires 15 days after original publication date. For more information about The Associated Press, please visit www.ap.org .
Similar stories from PHYSorg:
Anemia drugs under scrutiny
Mar 13, 2008 |
5 / 5 (1) |
0
Transfusions increase clot risk in hospitalized cancer patients
Nov 24, 2008 |
5 / 5 (2) |
0
FDA weighs approval of psychiatric drugs for kids
Jun 05, 2009 |
3 / 5 (2) |
3
Nanoparticle 'smart bomb' targets drug delivery to cancer cells
Feb 12, 2009 |
4.8 / 5 (5) |
1
FDA panel to vote on painkiller restrictions
Jun 30, 2009 |
2 / 5 (1) |
0

